Avalo Therapeutics Inc
AVTX
NASDAQ
Biotechnology
$19.59
USD
+0.14 (+0.72%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.04B
Volume 387.5K
Price Target
$30.00 – $58.00
USD
The 4 analysts offering 1-year price forecasts have a max estimate of $58.00 and a min estimate of $30.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$40.25
-$8.1 vs prior
Implied Upside
+105.5%
-41.5% vs prior
Analyst Covering
4
-4 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
33%
Many ratings are older - consensus may be less current
Analyst Agreement
Low
Targets are widely dispersed - limited agreement on price
Mean vs Median
$3.75 Gap
Median $36.50 vs avg $40.25 - a few bullish outliers are pulling the average up
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
4 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
4
Hold
0
Sell
0
Strong Sell
0
4 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Mitchell S. Kapoor | HC Wainwright & Co. | Buy | Maintained | 1 week ago | Plus | Plus | Plus |
Thomas Smith | Leerink Partners | Buy | Initiated | 1 month ago | Plus | Plus | Plus |
Julian Harrison | BTIG | Buy | Reiterated | 2 months ago | Plus | Plus | Plus |
Alec Stranahan | B of A Securities | Buy | Initiated | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
